DRW Securities’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
DRW Securities's LLY Position: Q2 2026 in Review
DRW Securities sold out of Eli Lilly (LLY) in Q2 2026, closing a stake of 459 shares — an estimated $469K sold.
DRW Securities first reported a position in LLY in Q4 2017 and held it in 20 quarters. The position peaked at $9.1M in Q1 2025. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- DRW Securities reported no remaining Eli Lilly position as of Q2 2026 after selling out during the quarter.
- DRW Securities sold 459 Eli Lilly shares in Q2 2026, an estimated $469K.
- DRW Securities first reported a position in Eli Lilly in Q4 2017 and held it in 20 quarters.
- DRW Securities's Eli Lilly position peaked at $9.1M in Q1 2025.
- 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on DRW Securities's 13F filing for Q2 2026, filed 14 Aug 2026.